CGH
RGEN icon

Crossmark Global Holdings’s Repligen RGEN Stock Holding History

Crossmark Global Holdings’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$597K Buy
4,373
+367
+9% +$45.1K 0.01% 808
2026
Q1 		$472K Buy
4,006
+147
+4% +$20.5K 0.01% 844
2025
Q4 		$632K Buy
3,859
+408
+12% +$63.9K 0.01% 752
2025
Q3 		$461K Sell
3,451
-481
-12% -$58.4K 0.01% 929
2025
Q2 		$489K Sell
3,932
-176
-4% -$22.4K 0.01% 894
2025
Q1 		$523K Buy
4,108
+167
+4% +$25.7K 0.01% 860
2024
Q4 		$567K Sell
3,941
-127
-3% -$18.2K 0.01% 779
2024
Q3 		$606K Buy
4,068
+436
+12% +$62.5K 0.01% 784
2024
Q2 		$458K Sell
3,632
-437
-11% -$68.5K 0.01% 874
2024
Q1 		$748K Buy
4,069
+264
+7% +$50.3K 0.01% 713
2023
Q4 		$684K Sell
3,805
-319
-8% -$49.7K 0.01% 722
2023
Q3 		$640K Sell
4,124
-104
-2% -$17K 0.01% 718
2023
Q2 		$737K Sell
4,228
-347
-8% -$55.6K 0.02% 690
2023
Q1 		$770K Buy
4,575
+181
+4% +$32.3K 0.02% 657
2022
Q4 		$744K Buy
4,394
+37
+0.8% +$6.71K 0.02% 646
2022
Q3 		$815K Buy
4,357
+7
+0.2% +$1.48K 0.02% 602
2022
Q2 		$707K Sell
4,350
-40
-0.9% -$6.33K 0.02% 678
2022
Q1 		$826K Sell
4,390
-330
-7% -$62.7K 0.02% 697
2021
Q4 		$1.25M Sell
4,720
-2,360
-33% -$636K 0.03% 563
2021
Q3 		$2.05M Sell
7,080
-380
-5% -$97.5K 0.05% 377
2021
Q2 		$1.49M Sell
7,460
-350
-4% -$67.9K 0.04% 478
2021
Q1 		$1.52M Buy
7,810
+10
+0.1% +$2.05K 0.04% 456
2020
Q4 		$1.5M Buy
7,800
+440
+6% +$80.1K 0.04% 451
2020
Q3 		$1.09M Buy
7,360
+80
+1% +$11.4K 0.03% 513
2020
Q2 		$900K Buy
7,280
+850
+13% +$100K 0.03% 564
2020
Q1 		$621K Sell
6,430
-40
-0.6% -$3.86K 0.02% 590
2019
Q4 		$598K Buy
6,470
+180
+3% +$15.1K 0.02% 720
2019
Q3 		$482K Sell
6,290
-10
-0.2% -$875 0.01% 796
2019
Q2 		$541K Sell
6,300
-180
-3% -$12.3K 0.02% 775
2019
Q1 		$383K Sell
6,480
-90
-1% -$5.18K 0.01% 986
2018
Q4 		$347K Sell
6,570
-3,910
-37% -$229K 0.01% 981
2018
Q3 		$581K Buy
10,480
+340
+3% +$17.5K 0.01% 859
2018
Q2 		$477K Buy
10,140
+410
+4% +$16.9K 0.01% 980
2018
Q1 		$352K Sell
9,730
-760
-7% -$26.7K 0.01% 1154
2017
Q4 		$381K Buy
10,490
+4,190
+67% +$152K 0.01% 1202
2017
Q3 		$241K Buy
+6,300
New +$264K 0.01% 1462
2016
Q3 		$241K Buy
+6,300
New +$190K 0.01% 1462

Other funds holding RGEN

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
CF
Covea Finance Paris, France $3.17B AUM 35.01% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Crossmark Global Holdings's RGEN Position: Q2 2026 in Review

Crossmark Global Holdings increased its Repligen (RGEN) stake by 9.2% in Q2 2026, buying an estimated $45.1K and bringing the position to 4,373 shares worth $597K. The position accounts for 0.01% of the portfolio, ranked #808.

Crossmark Global Holdings first reported a position in RGEN in Q3 2016 and has held it in 37 quarters since. The position peaked at $2.05M in Q3 2021. 48 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Crossmark Global Holdings held 4,373 shares of Repligen worth $597K as of Q2 2026.
  • Crossmark Global Holdings bought 367 Repligen shares in Q2 2026, an estimated $45.1K.
  • Repligen made up 0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #808 holding.
  • Crossmark Global Holdings first reported a position in Repligen in Q3 2016 and has held it in 37 quarters since.
  • Crossmark Global Holdings's Repligen position peaked at $2.05M in Q3 2021.
  • 48 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.